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Objectives: Pain catastrophizing has been associated with higher
pain intensity, increased risk of developing chronic pain and poorer
outcomes after treatment. Despite this, the mechanisms by which
pain catastrophizing inﬂuences pain remain poorly understood. It
has been hypothesized that pain catastrophizing may impair
descending inhibition of spinal level nociception. The aims of this
study were to compare spinal nociceptive processing in people with
chronic widespread pain and pain-free controls and examine
potential relationships between measures of pain catastrophizing
and spinal nociception.
Materials and Methods: Twenty-six patients with chronic wide-
spread pain and 22 pain-free individuals participated in this study.
Spinal nociception was measured using the nociceptive ﬂexion
reﬂex (NFR) threshold and NFR inhibition, measured as the
change in NFR area during exposure to a second, painful con-
ditioning stimulus (cold water immersion). Pain catastrophizing
was assessed using the Pain Catastrophizing Scale and a situational
pain catastrophizing scale.
Results: Compared with pain-free controls, patients with chronic
widespread pain had higher pain catastrophizing scores and lower
NFR thresholds. Although NFR area was reduced by a painful
conditioning stimulus in controls, this was not apparent in indi-
viduals with chronic widespread pain. No signiﬁcant correlations
were observed between measures of pain catastrophizing and spinal
nociception.
Discussion: Despite increased excitability and decreased inhibition
of spinal nociception in patients with chronic widespread pain, we
could ﬁnd no evidence of a signiﬁcant relationship between pain
catastrophizing and measures of spinal nociceptive processing.
Key Words: nociceptive ﬂexion reﬂex, pain catastrophizing, chronic
widespread pain
(Clin J Pain 2017;33:804–810)
Chronic widespread pain (CWP), deﬁned as pain for atleast 3 months aﬀecting the trunk, upper and lower
quadrants and both sides of the body,1 has an estimated
prevalence of 7% to 13%2 and is considered to be the
cardinal symptom of ﬁbromyalgia (FM). There is consid-
erable overlap in the clinical features of ﬁbromyalgia and
CWP, such as the presence of fatigue, sleep disturbances,
depression, and cognitive impairments,3,4 and it has been
suggested that these conditions may ﬁt on a clinical
continuum.5
CWP may be associated with abnormal nociceptive
system processing characterized by central sensitization and
signs of allodynia and hyperalgesia.6,7 In support of this,
people with FM have reduced nociceptive ﬂexion reﬂex
(NFR) thresholds,8,9 heightened temporal summation of
pain,10 and prolonged after sensations following repetitive
painful stimuli.10 Deﬁcient endogenous pain inhibition has
also been implicated in chronic widespread pain and
FM,11,12 with several studies reporting impaired con-
ditioned pain modulation (CPM) eﬃcacy13–15 and reduced
concentrations of key neurotransmitters involved in
descending inhibitory pathways, including serotonin,
norepinephrine, and dopamine.16,17
Psychological factors are known to play an important
role in the pain experience. Pain catastrophizing, which
involves magniﬁcation, helplessness, and rumination about
pain, is associated with higher pain intensity in ﬁbro-
myalgia18,19 and other chronic pain conditions. The long-
term consequences of pain catastrophizing include a greater
risk for the development and worsening of chronic
pain.20–22 Furthermore, it has been shown that reductions
in pain catastrophizing during psychologically based pain
treatments may mediate positive outcomes23–25 and that
early changes in pain catastrophizing during multi-
disciplinary pain treatment are linked with later improve-
ments in pain intensity.26,27 More recently, situational
measures of catastrophizing have been developed, with
these also found to correlate with measures of pain sensi-
tivity and clinical pain intensity.28–30
It is possible that pain catastrophizing has a direct
eﬀect on descending inhibitory pathways, as areas of the
brain mediating attention and pain aﬀect are part of a
network involved in the descending modulation of spinal
nociception.31–34 In this regard, a recent study35 showed
that a cognitive-behavioral therapy intervention reduced
secondary hyperalgesia, a biomarker of central sensitiza-
tion. Of relevance, the amount that pain catastrophizing
reduced with the intervention was associated with the size
of the reduction in secondary hyperalgesia. Such a ﬁnding
may reﬂect altered descending modulation of spinal noci-
ceptive processing. Indeed, there is evidence in healthy
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controls that pain catastrophizing is associated with
reduced CPM eﬃcacy.36,37 However, in these studies, CPM
eﬃcacy was assessed as the modiﬁcation of pain ratings of a
test stimulus in response to a second, painful conditioning
stimulus. As the CPM induced change in test pain ratings is
thought to reﬂect both cortico-cortical inhibition31,32 and
descending inhibition of spinal nociception,38 it is diﬃcult
to determine from these studies whether pain catastroph-
izing alters nociceptive processing at a spinal and/or
supraspinal level. The NFR provides an objective measure
of spinal nociceptive processing.39 As such, the NFR can be
used to directly examine the eﬀect of descending pathways
on spinal nociception. Several studies in healthy40,41 and
other chronic pain populations42,43 have thus far failed to
show a signiﬁcant association between measures of pain
catastrophizing and NFR threshold, a static measure of
excitability in spinal nociceptive pathways. Alternatively,
the NFR can be utilized within a CPM paradigm to
examine the dynamic modulation of spinal nociceptive
processing by endogenous pain inhibitory and/or facili-
tatory pathways. This is commonly achieved by examining
changes in the size of the average NFR electromyography
(EMG) response with (conditioned) and without (test) a
painful conditioning stimulus such as immersion of the
hand in cold water. Using such an approach, studies44,45
have observed impaired descending inhibition of spinal
nociceptive processing in chronic pain populations, com-
pared with pain-free controls. Given the consistent rela-
tionships observed between pain catastrophizing, pain
intensity, and pain-related treatment outcomes, it may be of
interest to determine if pain catastrophizing is associated
with descending modulation of the NFR, particularly in a
population with chronic pain. Thus, the aims of the present
study were to compare NFR threshold and descending
modulation of NFR area in healthy, pain-free controls and
individuals with CWP and to explore the possible rela-
tionships between these measures and pain catastrophizing.
Our hypotheses were that: (1) NFR threshold would be
lower in people with chronic widespread pain compared
with controls; (2) NFR area would be signiﬁcantly reduced
by a painful conditioning stimulus in controls, but not in
people with chronic widespread pain; and (3) there would
be a signiﬁcant association between measures of pain catas-
trophizing and descending modulation of the NFR, such
that greater catastrophizing would be associated with less
inhibition of the NFR area.
MATERIALS AND METHODS
Participants
Twenty-six people with CWP were recruited from a
hospital based multidisciplinary pain service, volunteering
to participate in the study (Table 1). A sample size of 26
allowed 80% power to detect a clinically relevant associa-
tion of r=0.48 between pain catastrophizing and NFR
inhibition at an alpha level of 0.05. Before volunteering for
the study, all participants in the CWP group were assessed
and diagnosed by a physician with specialist qualiﬁcations
in pain medicine. To be eligible, participants had to meet the
American College of Rheumatology’s 1990 diagnostic cri-
teria for CWP, requiring axial pain in addition to pain in the
upper and lower quadrants and right and left sides of the
body for at least 3 months.1 A control group of 22 pain-free
participants of a similar age and sex balance was also
recruited from ﬂyers on a local university notice board.
All participants had to be a ﬂuent English speaker and
reader. Participants were excluded if they were younger
than 18; had a history of major psychiatric illness (eg,
schizophrenia, bipolar disorder); had a known medical
condition that could account for the widespread nature of
their pain (eg, rheumatoid arthritis, cancer); had a docu-
mented loss of normal sensory perception or a neurological
condition that could interfere with quantitative sensory
testing procedures (eg, polyneuropathy); were currently
pregnant; or had any condition that may prevent weight-
bearing on 1 leg to collect NFR responses.
Before testing, all participants were asked to refrain
from taking analgesics for 24 hours and to abstain from
caﬀeine, nicotine, alcohol, and strenuous exercise for at
least 4 hours. Female participants were tested between days
17 and 28 of the menstrual cycle to reduce the potential
eﬀects of hormonal ﬂuctuations on the NFR.46 All study
procedures were approved by the local Ethics Committee
and informed consent was gained before initiation of study
procedures.
Procedures
All participants attended a single test session lasting 60
to 90 minutes. Participants ﬁrst completed questionnaire
data, including the Short-Form McGill Pain Questionnaire
(SF-MPQII), the Widespread Pain Index, and the Pain
Catastrophizing Scale (PCS). The SF-MPQII consists of 22
common words used to describe pain and related symptoms
and asks participants to rate each of these on a numerical
rating scale from 0 (none) to 10 (worst possible) in relation
to their own pain experience.47 The Widespread Pain Index
is calculated by dividing a body chart into 19 predeﬁned
regions and counting how many of these regions are (par-
tially or completely) shaded in when the participant com-
pletes a pain drawing.48 The PCS is a 13-item self-report
questionnaire which asks participants to rate the extent to
which they agree with statements regarding their thoughts
and feelings during previous painful experiences.49 Fol-
lowing completion of the questionnaires, NFR responses
were collected, as outlined below. Technical diﬃculties
meant that measures of NFR inhibition were only possible
in 22 of the 26 participants with CWP. However, NFR
threshold was recorded for all 26 participants. All NFR
measures were completed in the control participants. Fol-
lowing the NFR measures, situational pain catastrophizing
was assessed using the 6-item “in vivo/situational” version
of the PCS.28 Participants were asked to answer the
TABLE 1. Participant Demographic and Clinical Characteristics
Widespread Pain Control
Age (y) 46±13 46±13
Sex 23/26 female 21/22 female
BMI (kg/m2) 28.2±6.1 25.4±5.1
Duration of pain (y) 11±9 —
SF-MPQII (max 220) 88±37 —
WPI (max 19) 13±3 —
PCS (max 52) 22±14.9 6.7±8.2*
Values shown are mean±SD.
*Signiﬁcant diﬀerence between groups (P<0.001).
BMI indicates body mass index; PCS, Pain Catastrophizing Scale; SF-
MPQII, Short-Form McGill Pain Questionnaire II; WPI, Widespread Pain
Index.
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questions in relation to their thoughts and feelings during
the painful testing procedures they had just experienced.28
NFR Threshold
The NFR was elicited by electrocutaneously stim-
ulating the plantar aspect of the foot of the dominant leg.50
Responses were recorded in the biceps femoris muscle using
surface EMG. All EMG recordings were ampliﬁed
(1000), ﬁltered (10 to 1000Hz; AMT-8 ampliﬁer; Bortec
Biomedical, Alberta, Canada), and sampled at 2000Hz
(Micro 1401; Cambridge Electronic Design, Cambridge,
UK). Following skin preparation, the stimulating electrode
(D.O. Weaver & Co., Colorado) was placed 2 cm proximal
to the joint line of the ﬁrst metatarsophalangeal joint, with
the anode positioned distally. Each stimulation consisted of
a train of 5 rectangular pulses (perceived as a single stim-
ulus) of 1ms pulse width with a 3ms interpulse interval
(17ms total duration) delivered using a constant current
electrical stimulator (Digitimer DS7A, Hertfordshire, UK).
To reduce habituation and/or predictability, a random
interval of 8 to 12 seconds separated each stimulus. A
bipolar (AgCl) recording electrode (Norotrode) was placed
over the biceps femoris, 10 cm proximal to the popliteal
crease, with a ground electrode placed on the proximal
tibia. All testing was performed with the participant
standing on a 26 cm box on the nondominant leg, enabling
the dominant leg to hang freely. A handrail was provided
for support. Quiescence in the biceps femoris muscle of the
dominant leg was ensured by continuous monitoring of the
real-time EMG signal on an oscilloscope (Textronix
TDS2014B, Beaverton, Oregon).50 This method of eliciting
the NFR has been shown to be reliable as well as more
comfortable for participants when compared with tradi-
tional methods involving sural nerve stimulation in a seated
position.50
To allow participants to be familiarized with the pro-
cedures, 20 electrocutaneous stimuli of random intensity
were ﬁrst delivered to the foot. The NFR threshold was
then determined using an established staircase method and
a Z-score ofZ10.32 to determine whether a true reﬂex was
present or not, using the following formula: Z-score=
(NFR interval peak EMG–baseline EMG mean)/baseline
EMG SD.51 The NFR interval was deﬁned as the period 85
to 150ms after electrocutaneous stimulation, while baseline
EMG activity was measured in a period 70 to 5ms before
stimulation. Stimulation intensity was increased in incre-
ments of 4mA until a NFR was detected, then decreased in
2mA increments until a reﬂex was no longer present. This
procedure was repeated using 1mA increments until the
reﬂex appeared and disappeared 2 further times. The mean
of the ﬁnal 4 stimulation intensities was then determined
and a further 4 stimuli were delivered at this intensity.
If 3 of 4 stimuli elicited a NFR, this intensity was consid-
ered to be the NFR threshold. If fewer than 3 of 4 stimuli
elicited a NFR, the intensity was increased in 1mA incre-
ments until 3 or more NFR responses were elicited, which
was then taken as NFR threshold.52
Descending Modulation of the NFR
Descending modulation of the NFR was then eval-
uated by collecting 2 sets of NFR responses, 10 at baseline
(test responses), and 10 during painful cold water immer-
sion of the contralateral hand (conditioned responses).
Each of the 10 stimuli was separated by a randomized
interstimulus interval of 4 to 8 seconds. A stimulation
intensity of 120% to 200% of NFR threshold was used
depending on participant tolerance and to ensure a reﬂex
response was consistently elicited. For each participant, the
stimulation intensity was kept the same for the test and
conditioned responses. After the test responses were col-
lected, a 2-minute break was given, before participants
underwent cold water immersion by submerging the
contralateral hand up to the wrist crease in circulating 101C
water. After 1-minute of submersion, a set of 10 con-
ditioned responses were collected using identical stim-
ulation parameters. At the conclusion of the conditioned
responses, participants were asked to remove their hand
from the cold water and rate the maximum pain associated
with the cold water immersion on a scale from 0=no pain
to 100=maximum tolerable cold pain. If participants
could not tolerate the cold water immersion for the full time
to complete the 10 stimuli, they were allowed to withdraw
their hand and a hand pain rating of 100 was allocated, as
this represented their maximum tolerable cold pain. Where
this occurred, the second set of (conditioned) NFR
responses were still collected and were completed within a
maximum of 90 seconds after hand withdrawal. To calcu-
late NFR area, the signals were ﬁrst rectiﬁed and averaged
after the removal of any frames that contained background
muscle activity before stimulation (<5% of responses). The
area of the NFR was measured separately for the test and
conditioned responses using the averaged, rectiﬁed EMG
responses in a period 85 to 150ms after stimulation.
Statistical Analysis
Shapiro Wilk tests were undertaken to examine the
normality of the distribution for all variables of interest,
and thus the suitability of parametric analysis. All variables
of interest apart from NFR threshold were non-normally
distributed. As such, between group comparison of NFR
threshold was made using an independent sample t-test
while between group comparisons of pain catastrophizing,
situational pain catastrophizing, peak pain rating of the
conditioning stimulus (cold water immersion) and NFR
area stimulus (% threshold) were made using the Mann-
Whitney U-test. For each group, diﬀerences in NFR area
between the test and conditioned responses were examined
using the Wilcoxon signed-rank tests. For both the CWP
group and the control group, a Spearman rank correlation
coeﬃcient was used to examine the relationships between
(1) pain catastrophizing and NFR threshold; (2) pain cat-
astrophizing and NFR modulation (percent change in NFR
area between test and conditioned responses); (3) situa-
tional pain catastrophizing and NFR threshold; and (4)
situational pain catastrophizing and NFR modulation
(percent change in NFR area between test and conditioned
responses). Statistical signiﬁcance was set at P<0.05.
Results are reported as mean±SD. Eﬀect size estimates
were calculated using the formula: mean 1mean 2/pooled
SD.53 The strength of the eﬀect can be interpreted as 0.2 to
0.49=small; 0.5 to 0.79=medium; Z0.8= large).53
RESULTS
Table 1 shows summary demographic and clinical
information for the 2 groups. The CWP group demonstrated
signiﬁcantly higher pain catastrophizing on the PCS
(Z=4.09; P<0.001; eﬀect size=1.39). No signiﬁcant
between group diﬀerence was found for situational pain
catastrophizing (Z=1.19; P>0.05; eﬀect size=0.44).
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NFR data for the 2 groups are shown in Table 2. The
CWP group displayed signiﬁcantly lower NFR thresholds
than the control group (t= 3.06; P<0.01; eﬀect size=
0.88). There was no signiﬁcant diﬀerence in the test stim-
ulus intensity (% of NFR threshold) used to elicit NFR
area between groups (Z= 0.94; P>0.05). The control
group had a signiﬁcantly smaller NFR area (Z= 3.30;
P<0.001; eﬀect size= 0.17) during the conditioned
responses compared with the test responses. In contrast,
NFR area (Z= 1.64; P>0.05; eﬀect size= 0.05) did
not change during the conditioned responses in the CWP
group. The peak pain induced by the conditioning stimulus
was signiﬁcantly higher in the CWP group than in the
control group (Z= 3.29; P=0.01, eﬀect size=0.83).
The conditioning stimulus was unable to be tolerated for
the full amount of time in 5% of the control group and
32% of the CWP group.
The Spearman rho data for the CWP and control
groups are presented separately in Table 3. There were no
signiﬁcant correlations between measures of pain cata-
strophizing and spinal nociceptive processing in either the
CWP group or control group (all P>0.05).
DISCUSSION
An important ﬁnding of this study was that the
NFR area was not inhibited by a painful conditioning stimulus
in individuals with CWP. In contrast, signiﬁcant inhibition of
the NFR area was observed in the pain-free control group.
This supports several other studies that have shown impaired
CPM eﬃcacy in CWP and/or FM,13–15,54 thought to at least
partly reﬂect a dysfunction in the normal descending modu-
lation of spinal nociception. In contrast to previous work, the
current study used the NFR to directly examine descending
modulation of spinal nociception in people with CWP. As
such, the lack of NFR inhibition with a painful conditioning
stimulus provides direct evidence of impaired descending
inhibition and/or enhanced descending facilitation of spinal
level nociceptive processing in this population.
The NFR threshold was also signiﬁcantly lower in
individuals with CWP compared with the control group,
providing further evidence of altered nociceptive processing.
This ﬁnding supports recent studies which have demon-
strated consistently lower NFR thresholds in ﬁbromyalgia
and other chronic pain conditions compared with healthy
pain-free populations.55,56 As wide dynamic range neurons
are thought to play a critical role in mediating the NFR
response,57 a reduced NFR threshold in the CWP group
may indicate heightened spinal nociceptive sensitivity due to
central sensitization of wide dynamic range neurons within
the dorsal horn.
No other studies have speciﬁcally explored the rela-
tionships between pain catastrophizing and measures of
spinal nociceptive processing in individuals with CWP.
Our ﬁndings provide no evidence of an important rela-
tionship between measures of pain catastrophizing and
measures of spinal nociceptive processing in this pop-
ulation, or in pain-free controls. This was evident using
both standard and situational measures of pain catas-
trophizing. It has been shown that CPM is inﬂuenced by
expectations38,39 and can be modiﬁed by verbal sugges-
tion,58 demonstrating that cognitive factors can alter the
eﬃcacy of endogenous pain modulatory pathways. How-
ever, ﬁndings from studies relating neurophysiological
measures of nociceptive system function to psychological
factors such as catastrophizing are inconsistent. Our
ﬁndings support several other studies that have shown no
relationship among these factors in people with other
chronic pain conditions56,59–63 or in healthy controls.64–66
In contrast, some studies have reported that pain cata-
strophizing is related to various measures of endogenous
pain inhibition or facilitation.44,63,67–69 Typically, these
studies have found that greater pain catastrophizing is
associated with enhanced facilitation of pain and/or
impaired inhibition. It is possible that discrepancies
among study protocols may account for some
of the diﬀerent outcomes. Diﬀerent measures, including
those relying solely on pain report, as well as diﬀerent
forms of conditioning and test stimuli (eg, mechanical,
electrical, thermal) have been used among the studies,
which likely inﬂuences the precise component of the
nociceptive system under study. The chronic pain pop-
ulation studied may also inﬂuence ﬁndings. For example,
Hassett et al19 found that catastrophizing had a greater
inﬂuence on pain intensity in women with FM than in
women with rheumatoid arthritis, suggesting that the
inﬂuence of catastrophizing may be diﬀerent among pain
conditions.
The ﬁndings of the current study suggest that catas-
trophizing may primarily aﬀect nociceptive processing at a
supraspinal, rather than a spinal level CWP. In support of
this, Ruscheweyh et al70 recently examined the eﬀect of
catastrophizing statements on nociceptive NFR area and
temporal summation of pain in healthy, pain-free
TABLE 2. Nociceptive Flexion Reflex and Situational Pain
Catastrophizing Summary Data for Chronic Widespread Pain and
Control Groups
Widespread
Pain Control
NFR threshold (mA) 15.2±7.5 22.0±7.9*
NFR area stimulus (% NFR
threshold)
148±15 155±32
Test NFR area (mV.ms) 4.65±9.65 1.55±1.20
Conditioned NFR area (mV.ms) 4.12±12.05 1.35±1.11w
Pain intensity of conditioning
stimulus
71±27 44±22*
Sit PCS (max 24) 9±7.7 5.7±4.7
Values shown are mean±SD.
*Signiﬁcant diﬀerence (P<0.05) between groups.
wSigniﬁcant (P<0.05) diﬀerence from test (unconditioned) response.
NFR indicates nociceptive ﬂexion reﬂex; Sit PCS, situational pain cat-
astrophizing scale.
TABLE 3. Spearman’s Rho Values Between Pain Catastrophizing
Scale Scores and Measures of Spinal Nociceptive Processing in
Individuals With Chronic Widespread Pain and a Pain-Free
Control Group
CWP Group Control Group
PCS Sit PCS PCS Sit PCS
NFR threshold 0.22 0.12 0.01 0.10
% change in NFR area 0.17 0.23 0.16 0.07
CWP indicates chronic widespread pain; NFR, nociceptive ﬂexion reﬂex;
PCS, pain catastrophizing scale; Sit PCS, situational pain catastrophizing
scale.
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individuals. Catastrophizing increased both pain ratings
and NFR area but the increase in pain ratings was much
greater, leading the authors to suggest that catastrophizing
predominantly acted at a supraspinal level to modify
nociceptive processing, a ﬁnding supported by other
observations.64–66 Taken together, these ﬁndings suggest
that factors other than pain catastrophizing may contribute
to increased excitability and impaired descending modu-
lation of spinal nociception. Furthermore, treatments
aimed at modifying pain catastrophizing (eg, cognitive-
behavioral therapy) are less likely to signiﬁcantly alter
spinal nociceptive processing, as has recently been demon-
strated in healthy controls.41 As such, additional inter-
ventions (eg, antidepressant medications) may be needed to
eﬀectively reduce sensitization of spinal nociceptive path-
ways and maximize pain relief. To further enhance our
understanding of the mechanisms by which catastrophizing
aﬀects the pain experience, future research should utilize
longitudinal study designs to examine the eﬀects of a clin-
ical intervention aimed at reducing pain catastrophizing on
measures of spinal and supraspinal nociceptive processing
in chronic pain populations.
A limitation of the current study is that we did not
measure participants’ expectation regarding the eﬀects of
the conditioning stimulus on NFR area. Previous studies
have shown that verbally induced expectations of analgesia
or hyperalgesia can modify the eﬀects of the conditioning
stimulus, even at a spinal level.38,71 In contrast, when no
attempt is made to manipulate participant expectation
before applying the conditioning stimulus, other studies72,73
have found no association between a priori expectation and
the analgesic eﬀects associated with CPM. Future studies
may wish to examine the role of conditioning stimulus
expectation and whether this may partially explain the
deﬁcient CPM response that is often observed in chronic
pain populations.74 Another possible limitation of the
current study is that the peak pain associated with the
conditioning stimulus was not matched between the 2
groups, with the CWP group reporting higher intensity pain
in response to cold water immersion of the hand at 101C.
This is unlikely to have inﬂuenced the results markedly as
several studies have shown no association between con-
ditioning pain intensity and the extent of CPM.75–77
Moreover, one might expect that the higher cold pain
intensity reported in the CWP group may lead to stronger
inhibition of the NFR but in fact, we observed the opposite,
with no signiﬁcant inhibition of NFR area in the CWP
group and an intact inhibitory response in controls. Finally,
the conditioning stimulus was unable to be tolerated for the
full amount of time by 5% of the control group and 32% of
the CWP group. When this occurred, the second set of
NFR responses were still collected and completed within a
maximum time of 90 seconds after hand withdrawal. As the
inhibitory response is known to persist for several minutes
after the conditioning stimulus has ceased,77–79 we do not
anticipate that this had an important bearing on our results.
CONCLUSIONS
Compared with pain-free control participants, we
observed a lower NFR threshold and reduced descending
inhibition of the NFR in people with CWP. However, we
could not demonstrate a signiﬁcant relationship between
measures of spinal nociceptive processing and pain cata-
strophizing in these participants, providing further evidence
that pain catastrophizing may largely modify nociceptive
processing at a supraspinal rather than a spinal level, even
in individuals with chronic pain.
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